Sorrento Therapeutics Reports Data On STI-1499 And STI-2020 Neutralizing Antibodies Against SARS-CoV-2
Hasnain R
September 29, 2020
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) announced today the result of COVI-GUARD™ (STI-1499) and COVI-AMG™ (STI-2020) neutralizing antibodies (nAbs) against SARS-CoV-2. Both the STI-1499 and STI-2020